Innovation in cardiovascular medicine is not limited to the interventional area. The turn of the millennium brought concerns that advances in cardiovascular medicine may decline however new device technologies have since generated a renaissance in cardiovascular innovation. A similar rejuvenation is now happening in preventive cardiology. Modern personalized approaches to cardiovascular treatment should combine innovative prevention on a population level with state-of-the-art interventional treatment.
CVD is the leading cause of death in women both in Europe and worldwide. Yet, women with CVD are typically underdiagnosed and undertreated compared to men. This year’s theme will highlight initiatives in closing the gap in the cardiovascular care of women.
This Summit is ideal for both preventive and interventional cardiologists.
Prevention is intervention, and intervention is prevention!